|
MEDTRONIC IRELAND ENDURANT ILIAC STENT GRAFT; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
|
Back to Search Results |
|
| Model Number |
ENEW2424C82E |
| Medical Device Problem Code |
Leak/Splash (1354)
|
| Health Effect - Clinical Code |
Injury (2348)
|
| Date of Event |
07/08/2020
|
|
Type of Reportable Event
|
Serious Injury
|
|
Additional Manufacturer Narrative
|
|
Other relevant device(s) are: product id: unknown, sn: unknown, ubd: unknown, udi#: unknown.If information is provided in the future, a supplemental report will be issued.
|
| |
|
Event or Problem Description
|
|
An endurant abdominal stent graft system was implanted in the endovascular treatment of a unknown sized abdominal aortic aneurysm located in the iliac artery.It was reported that during follow-up, approximately 8.5 years post index procedure, a ct was performed.It was stated that the two devices implanted in the left iliac artery had separated and a type iiia endoleak was observed.It was reported that a limb was implanted and the event was resolved.As per the physician, cause of the event cannot be determined.No additional clinical sequelae were reported and the patient is fine.
|
| |
|
Additional Manufacturer Narrative
|
|
Other relevant devices updated; enlw1624c124e, s/n: (b)(6) use by date: 2013-11-27 upn#: 00613994761880.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.
|
| |
|
Search Alerts/Recalls
|
|
|